U.S. News & World Report Was FDA Lax in Approving Opioids Too Easily? Dr. Michael Sinha, a visiting scholar at the Center for Health Policy and Law at Northeastern University School of Law in Boston, said the results align with an earlier study of his that found most new pain medications tend to be reformulations of already approved prescription opioids.